Suppr超能文献

Survivin 一览。

Survivin at a glance.

机构信息

Department of Biochemistry, School of Life Sciences, University of Nottingham, Nottingham NG7 2UH, UK

The Wistar Institute Cancer Center, Philadelphia, PA 19104, USA.

出版信息

J Cell Sci. 2019 Apr 4;132(7):jcs223826. doi: 10.1242/jcs.223826.

Abstract

Survivin (also known as BIRC5) is an evolutionarily conserved eukaryotic protein that is essential for cell division and can inhibit cell death. Normally it is only expressed in actively proliferating cells, but is upregulated in most, if not all cancers; consequently, it has received significant attention as a potential oncotherapeutic target. In this Cell Science at a Glance article and accompanying poster, we summarise our knowledge of survivin 21 years on from its initial discovery. We describe the structure, expression and function of survivin, highlight its interactome and conclude by describing anti-survivin strategies being trialled.

摘要

存活素(也称为 BIRC5)是一种进化上保守的真核蛋白,对细胞分裂至关重要,并能抑制细胞死亡。通常情况下,它仅在活跃增殖的细胞中表达,但在大多数(如果不是全部)癌症中都上调;因此,它作为一种潜在的肿瘤治疗靶点受到了广泛关注。在这篇《细胞科学一瞥》文章及其配套海报中,我们总结了存活素自最初发现以来 21 年的研究进展。我们描述了存活素的结构、表达和功能,突出了其相互作用组,并在最后描述了正在试验的抗存活素策略。

相似文献

1
Survivin at a glance.Survivin 一览。
J Cell Sci. 2019 Apr 4;132(7):jcs223826. doi: 10.1242/jcs.223826.
6
Survivin as a Potential Target for Cancer Therapy.生存素作为癌症治疗的潜在靶点。
Asian Pac J Cancer Prev. 2015;16(15):6187-91. doi: 10.7314/apjcp.2015.16.15.6187.

引用本文的文献

3
Immunotherapy in Glioblastoma.胶质母细胞瘤中的免疫疗法。
Cancer Treat Res. 2025;129:103-118. doi: 10.1007/978-3-031-97242-3_6.

本文引用的文献

1
Recent advances in understanding inhibitor of apoptosis proteins.凋亡抑制蛋白研究的最新进展
F1000Res. 2018 Dec 3;7. doi: 10.12688/f1000research.16439.1. eCollection 2018.
8
Drugging the 'undruggable' cancer targets.针对“不可成药”的癌症靶点研发药物。
Nat Rev Cancer. 2017 Aug;17(8):502-508. doi: 10.1038/nrc.2017.36. Epub 2017 Jun 23.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验